AMBER FIELDS: Open Payments
NPI 1639629835 · GALLIPOLIS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 34 payments from 13 companies in 2025. Trend: 2023 $714 · 2024 $918 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Ardelyx, Inc. | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $38 |
| Travere Therapeutics, Inc. | 3 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: MAVYRET, IBSRELA, LINZESS, ENTYVIO, XIFAXAN, TREMFYA, CREON, EOHILIA.
Industry payments across OH — which companies pay providers there.
